LMAT
HEALTHCARELeMaitre Vascular Inc
AI Insight
What's Moving LMAT Today?
No stock-specific AI insight has been generated for LMAT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$78.29$117.72
$91.95
Fundamentals
Market Cap$2.0B
P/E Ratio32.6
EPS$2.72
Dividend Yield0.90%
Dividend / Share$0.85
ROE16.6%
Profit Margin24.3%
Debt / Equity—
Trading
Volume442K
Avg Volume (10D)—
Shares Outstanding22.9M
LMAT News
24 articles- 3 of Wall Street’s Favorite Stocks We Find RiskyYahoo Finance·Jun 2, 2026
- How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value TargetsYahoo Finance·May 29, 2026
- LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons WhyYahoo Finance·May 25, 2026
- 1 Reason to Avoid LMAT and 1 Stock to Buy InsteadYahoo Finance·May 22, 2026
- Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMATMarketBeat·May 21, 2026
- Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty StocksYahoo Finance·May 21, 2026
- LeMaitre to Participate at Upcoming Investor Conferences in JuneThe Manila Times·May 20, 2026
- LeMaitre schedules June talks at Jefferies and Goldman healthcare eventsStock Titan·May 20, 2026
- 3 Healthcare Stocks with Open QuestionsYahoo Finance·May 18, 2026
- 5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings CallYahoo Finance·May 15, 2026
- Why LeMaitre Vascular (LMAT) Is Down 10.9% After Raising 2026 Guidance And Boosting DividendsSimply Wall Street·May 14, 2026
- Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a TurnaroundYahoo Finance·May 13, 2026
- US$118 - That's What Analysts Think LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Worth After These ResultsYahoo Finance·May 7, 2026
- 3 Reasons Growth Investors Will Love LeMaitre (LMAT)Yahoo Finance·May 7, 2026
- LeMaitre (LMAT) Upgraded to Buy: Here's WhyYahoo Finance·May 7, 2026
- LeMaitre Vascular, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- LeMaitre Vascular Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- LeMaitre Vascular (LMAT) Tops Q1 Earnings EstimatesYahoo Finance·May 5, 2026
- LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With EstimatesYahoo Finance·May 5, 2026
- LeMaitre Q1 2026 Financial ResultsYahoo Finance·May 5, 2026
- LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look ForYahoo Finance·May 5, 2026
- NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next EntryYahoo Finance·May 4, 2026
- How Investors May Respond To LeMaitre Vascular (LMAT) Profit Boost From Strong Operating LeverageYahoo Finance·May 1, 2026
- LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should KnowThe Motley Fool·Mar 28, 2026
All 24 articles loaded
Price Data
Open$89.40
Previous Close$88.61
Day High$93.06
Day Low$89.30
52 Week High$117.72
52 Week Low$78.29
52-Week Range
$78.29$117.72
$91.95
Fundamentals
Market Cap$2.0B
P/E Ratio32.6
EPS$2.72
Dividend Yield0.90%
Dividend / Share$0.85
ROE16.6%
Profit Margin24.3%
Debt / Equity—
Trading
Volume442K
Avg Volume (10D)—
Shares Outstanding22.9M
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—